Consequently, the binding of PD-1 on CAR-T cells to PD-L1 on tumor cells initiates inhibitory signals, leading to compromised functionality of CAR-T cells [47] and facilitating immune evasion by tumor cells [48]. The gene discussed is CD274; the disease is neoplasm.